Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance-Reference-Cited by-全球学者库

Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance

Published:2023-05-23 Issue:6 Volume:10 Page:226
ISSN:2308-3425
Container-title:Journal of Cardiovascular Development and Disease
language:en
Short-container-title:JCDD

Author:

Stankowski Kamil¹²^ORCID,Figliozzi Stefano²^ORCID,Lisi Costanza¹²^ORCID,Catapano Federica¹²,Panico Cristina¹²^ORCID,Cannata Francesco¹²^ORCID,Mantovani Riccardo²,Frontera Antonio¹²,Bragato Renato Maria²,Stefanini Giulio¹²^ORCID,Monti Lorenzo²^ORCID,Condorelli Gianluigi¹²,Francone Marco¹²

Affiliation:

1. Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 4, Pieve Emanuele, 20090 Milano, Italy

2. Humanitas Research Hospital IRCCS, Via Alessandro Manzoni, 56, Rozzano, 20089 Milano, Italy

Abstract

Cardiac magnetic resonance (CMR) has been recently implemented in clinical practice to refine the daunting task of establishing the risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). We present an exemplificative case highlighting the practical clinical utility of this imaging modality in a 24-year-old man newly diagnosed with an apical HCM. CMR was essential in unmasking a high risk of SCD, which appeared low-intermediate after traditional risk assessment. A discussion examines the essential role of CMR in guiding the patient’s therapy and underlines the added value of CMR, including novel and potential CMR parameters, compared to traditional imaging assessment for SCD risk stratification.

Publisher

MDPI AG

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Link

https://www.mdpi.com/2308-3425/10/6/226/pdf

Reference60 articles.

1. Clinical Course and Management of Hypertrophic Cardiomyopathy;Maron;N. Engl. J. Med.,2018

2. New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy;Semsarian;J. Am. Coll. Cardiol.,2015

3. How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease with Low Mortality: Shaped by 50 Years of Clinical Research and Practice;Maron;JAMA Cardiol.,2016

4. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD);Jichi;Eur. Heart J.,2014

5. Comparison of the Prognostic Usefulness of the European Society of Cardiology and American Heart Association/American College of Cardiology Foundation Risk Stratification Systems for Patients with Hypertrophic Cardiomyopathy;Leong;Am. J. Cardiol.,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of cardiac magnetic resonance in hypertrophic cardiomyopathy over the past 10 years [2013–2023]: a CiteSpace-based bibliometric analysis;Quantitative Imaging in Medicine and Surgery;2024-01